S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Stocks are for suckers – try this instead (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
Stocks are for suckers – try this instead (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
Stocks are for suckers – try this instead (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
NYSE:CHE

Chemed - CHE Stock Forecast, Price & News

$537.75
+10.44 (+1.98%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$529.39
$538.75
50-Day Range
$493.18
$537.75
52-Week Range
$430.16
$539.13
Volume
99,545 shs
Average Volume
70,990 shs
Market Capitalization
$8.04 billion
P/E Ratio
32.53
Dividend Yield
0.28%
Price Target
$587.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.2% Upside
$587.00 Price Target
Short Interest
Healthy
2.97% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
0.16mentions of Chemed in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$4.69 M Sold Last Quarter
Proj. Earnings Growth
8.39%
From $20.85 to $22.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.60 out of 5 stars

Medical Sector

101st out of 996 stocks

Home Health Care Services Industry

4th out of 9 stocks


CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara Sells 3,000 Shares
This Tech Stock Could be the Next Amazon
You can learn its name in Luke Lango’s latest report, 5 Hypergrowth Stocks for 2023. Claim Your Free Report Here. pixel
Chemed Full Year 2022 Earnings: EPS Misses Expectations
This Tech Stock Could be the Next Amazon
You can learn its name in Luke Lango’s latest report, 5 Hypergrowth Stocks for 2023. Claim Your Free Report Here. pixel
Q4 2022 Chemed Corp Earnings Call
Chemed (CHE) Tops Q4 Earnings and Revenue Estimates
Chemed Reports Fourth-Quarter 2022 Results
Chemed Q4 2022 Earnings Preview
PNTG vs. CHE: Which Stock Is the Better Value Option?
Chemed (CHE) Q3 Earnings Surpass Estimates, EPS View Up
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
2/24/2023
Ex-Dividend for 3/17 Dividend
2/24/2023
Dividend Payable
3/17/2023
Today
4/02/2023
Next Earnings (Estimated)
4/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,167
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$587.00
High Stock Price Forecast
$587.00
Low Stock Price Forecast
$587.00
Forecasted Upside/Downside
+9.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$249.62 million
Pretax Margin
15.44%

Debt

Sales & Book Value

Annual Sales
$2.13 billion
Cash Flow
$24.62 per share
Book Value
$53.71 per share

Miscellaneous

Free Float
14,346,000
Market Cap
$8.04 billion
Optionable
Optionable
Beta
0.52

Social Links


Key Executives

  • Kevin J. McNamaraKevin J. McNamara
    President, Chief Executive Officer & Director
  • David Patrick WilliamsDavid Patrick Williams
    Chief Financial Officer & Executive Vice President
  • Spencer S. LeeSpencer S. Lee
    Executive Vice President
  • Nicholas M. WestfallNicholas M. Westfall
    Executive Vice President
  • Thomas C. Hutton
    Director & Vice President













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 brokers have issued 12-month price objectives for Chemed's stock. Their CHE share price forecasts range from $587.00 to $587.00. On average, they anticipate the company's share price to reach $587.00 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2023?

Chemed's stock was trading at $510.43 at the beginning of the year. Since then, CHE shares have increased by 5.4% and is now trading at $537.75.
View the best growth stocks for 2023 here
.

Are investors shorting Chemed?

Chemed saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 432,300 shares, a drop of 15.6% from the February 28th total of 512,000 shares. Based on an average trading volume of 73,600 shares, the short-interest ratio is currently 5.9 days. Currently, 3.0% of the company's shares are sold short.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its earnings results on Friday, February, 24th. The company reported $5.39 EPS for the quarter, topping the consensus estimate of $5.30 by $0.09. The company earned $546.65 million during the quarter, compared to analysts' expectations of $546.60 million. Chemed had a trailing twelve-month return on equity of 41.54% and a net margin of 11.69%. Chemed's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.25 earnings per share.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, February 17th. Stockholders of record on Monday, February 27th will be paid a dividend of $0.38 per share on Friday, March 17th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Friday, February 24th.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.29%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided earnings per share (EPS) guidance of $20.75-$21.10 for the period, compared to the consensus EPS estimate of $20.21. The company issued revenue guidance of $2.24 billion-$2.25 billion, compared to the consensus revenue estimate of $2.21 billion.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $537.75.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $8.04 billion and generates $2.13 billion in revenue each year. The company earns $249.62 million in net income (profit) each year or $16.53 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,167 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 4/2/2023 by MarketBeat.com Staff